References
- Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (DIRS): a prospective study. JAMA 1995; 273: 117–23.
- Linde-Zwirble WT, Angus DC, Garcillo J, Lidicker J, Clermont G, Dinsky MR. Age-specific incidence and outcome of sepsis in the US. Crit Care Med 1999; 27, (Suppl 1): A 33.
- Marshall JC. SIRS and MODS: What is their relevance to the science and practice of intensive care? Shock 2000; 15: 586–9.
- Murphy K, Haudek SB, Thompson M et al. Molecular biology of septic shock. New Horiz 1998; 6: 181–93.
- Heuman D, Glauser MP. Pathogenesis of sepsis. Sci Am Sci Med 1994; 1: 28–37.
- Glauser MP. Pathophysiology basis of sepsis: Considerations for future strategies of intervention. Crit Care Med 2000; 28, Suppl: S4-S8.
- Heuman D, Glauser MP, Calandra T. Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol 1998; 1: 49–55.
- Bernard GI, Vicent JL, Latorre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 698–709.
- Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in Intensive Care Units in Europe. JAMA 1995; 274: 639–344.